- Home
- ETV vs TWST Comparison
ETV vs TWST Comparison
Compare ETV & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETV
- TWST
- Stock Information
- Founded
- ETV 2005
- TWST 2013
- Country
- ETV United States
- TWST United States
- Employees
- ETV N/A
- TWST N/A
- Industry
- ETV Investment Managers
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ETV Finance
- TWST Health Care
- Exchange
- ETV Nasdaq
- TWST Nasdaq
- Market Cap
- ETV 1.7B
- TWST 1.6B
- IPO Year
- ETV N/A
- TWST 2018
- Fundamental
- Price
- ETV $13.92
- TWST $25.75
- Analyst Decision
- ETV
- TWST Buy
- Analyst Count
- ETV 0
- TWST 10
- Target Price
- ETV N/A
- TWST $47.50
- AVG Volume (30 Days)
- ETV 252.5K
- TWST 1.7M
- Earning Date
- ETV 01-01-0001
- TWST 11-14-2025
- Dividend Yield
- ETV 8.75%
- TWST N/A
- EPS Growth
- ETV N/A
- TWST N/A
- EPS
- ETV N/A
- TWST N/A
- Revenue
- ETV N/A
- TWST $376,572,000.00
- Revenue This Year
- ETV N/A
- TWST $17.89
- Revenue Next Year
- ETV N/A
- TWST $16.81
- P/E Ratio
- ETV N/A
- TWST N/A
- Revenue Growth
- ETV N/A
- TWST 20.32
- 52 Week Low
- ETV $11.05
- TWST $23.30
- 52 Week High
- ETV $13.50
- TWST $55.33
- Technical
- Relative Strength Index (RSI)
- ETV 36.51
- TWST 35.09
- Support Level
- ETV $14.02
- TWST $24.41
- Resistance Level
- ETV $14.46
- TWST $27.37
- Average True Range (ATR)
- ETV 0.17
- TWST 2.06
- MACD
- ETV -0.06
- TWST -0.75
- Stochastic Oscillator
- ETV 5.51
- TWST 22.45
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.